These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4148537)

  • 1. Studies on sweating in clinical and experimental thyrotoxicosis.
    Allen JA; Lowe DC; Roddie IC; Wallace WF
    Clin Sci Mol Med; 1973 Dec; 45(6):765-73. PubMed ID: 4148537
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of -adrenoceptor blockade on human sweating.
    Allen JA; Jenkinson DJ; Roddie IC
    Br J Pharmacol; 1973 Mar; 47(3):487-97. PubMed ID: 4147190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
    Bhatt P; Makwana D; Santani D; Goyal R
    Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Adrenergic receptor blockade does not modify non-thermal sweating during static exercise and following muscle ischemia in habitually trained individuals.
    Amano T; Igarashi A; Fujii N; Hiramatsu D; Inoue Y; Kondo N
    Eur J Appl Physiol; 2018 Dec; 118(12):2669-2677. PubMed ID: 30238251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of alpha- and beta adrenergic receptor blockaders on the secretory response of pancreatic beta cells in thyrotoxicosis].
    Zhurova TE; Lugovaia NA; Poltorak VV; Iurchenko MZ
    Ter Arkh; 1982; 54(10):36-9. PubMed ID: 6129711
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular response in hyperthyroidism. The influence of adrenergic-receptor blockade.
    Pietras RJ; Real MA; Poticha GS; Bronsky D; Waldstein SS
    Arch Intern Med; 1972 Mar; 129(3):426-9. PubMed ID: 4401571
    [No Abstract]   [Full Text] [Related]  

  • 7. Propranolol as primary therapy for thyrotoxicosis.
    Mazzaferri EL; Reynolds JC; Young RL; Thomas CN; Parisi AF
    Arch Intern Med; 1976 Jan; 136(1):50-6. PubMed ID: 1108824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic study of hyperthyroidism and variations induced by propranolol].
    Cayuela ML; Doval H; Bazzino O; Hermberg HC
    Medicina (B Aires); 1977; 37(3):223-31. PubMed ID: 19677
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid control of sweat gland function.
    Gibinski K; Powierza-Kaczynska C; Zmudzinski J; Giec L; Dosiak J
    Metabolism; 1972 Sep; 21(9):843-8. PubMed ID: 5057273
    [No Abstract]   [Full Text] [Related]  

  • 10. The enhanced myocardial contractility of thyrotoxicosis. Role of the beta adrenergic receptor.
    Grossman W; Robin NI; Johnson LW; Brooks HL; Selenkow HA; Dexter L
    Ann Intern Med; 1971 Jun; 74(6):869-74. PubMed ID: 4397167
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE STATUS OF CERTAIN PHYSIOLOGICAL ADRENERGIC RESPONSES IN ALBINO RATS DURING DEVELOPMENT OF EXPERIMENTAL HYPERTHYROIDISM].
    Osman NS; Ismail M
    Fiziol Zh (1994); 2015; 61(2):60-4. PubMed ID: 26387161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of beta-blocking agents on urinary excretion of 3-methylhistidine during experimental hyperthyroidism in rats.
    Angerås U; Jagenburg R; Lindstedt G; Hasselgren PO
    Eur Surg Res; 1987; 19(1):23-30. PubMed ID: 2878810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptor antagonism and the hyperthyroid rat heart.
    Amos G; Kerr D; Sernia C; Brown L
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):336-43. PubMed ID: 7526070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of propranolol on heart rate variability in hyperthyroidism.
    Tankeu AT; Azabji-Kenfack M; Nganou CN; Ngassam E; Kuate-Mfeukeu L; Mba C; Dehayem MY; Mbanya JC; Sobngwi E
    BMC Res Notes; 2018 Feb; 11(1):151. PubMed ID: 29471876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for β-adrenergic modulation of sweating during incremental exercise in habitually trained males.
    Amano T; Shitara Y; Fujii N; Inoue Y; Kondo N
    J Appl Physiol (1985); 2017 Jul; 123(1):182-189. PubMed ID: 28473612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of adrenergic alpha and beta receptor blockade to elevate the TSH and prolactin response to TRH in hyperthyroidism.
    Epstein S; Pimstone BL; Vinik AI; McLaren H
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):501-4. PubMed ID: 240525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged effect of nadolol on heart rate in hyperthyroidism.
    Adam RD; Parekh P; Harrower AD
    Curr Med Res Opin; 1981; 7(4):212-4. PubMed ID: 6112117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-adrenoceptor blockade on thermoregulation during prolonged exercise.
    Gordon NF; Krüger PE; Van Rensburg JP; Van der Linde A; Kielblock AJ; Cilliers JF
    J Appl Physiol (1985); 1985 Mar; 58(3):899-906. PubMed ID: 2858466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of propranolol on thyroid hormones and oxygen consumption in thyrotoxicosis.
    Saunders J; Hall SE; Crowther A; Sönksen PH
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):67-72. PubMed ID: 679503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative treatment of thyrotoxicosis with a beta-adrenergic blocking agent.
    Ljunggren JG; Persson B
    Acta Chir Scand; 1975; 141(8):715-8. PubMed ID: 3081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.